nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—head—melanoma	0.00408	0.165	CbGeAlD
Octreotide—SSTR2—eye—melanoma	0.00394	0.159	CbGeAlD
Octreotide—SSTR3—head—melanoma	0.00333	0.134	CbGeAlD
Octreotide—MPO—endothelium—melanoma	0.00304	0.123	CbGeAlD
Octreotide—MPO—blood vessel—melanoma	0.0028	0.113	CbGeAlD
Octreotide—SSTR1—head—melanoma	0.00263	0.106	CbGeAlD
Octreotide—SSTR2—head—melanoma	0.00224	0.0902	CbGeAlD
Octreotide—MPO—skin of body—melanoma	0.0013	0.0523	CbGeAlD
Octreotide—Menopausal symptoms—Docetaxel—melanoma	0.000847	0.0021	CcSEcCtD
Octreotide—MPO—head—melanoma	0.000847	0.0341	CbGeAlD
Octreotide—Visual disturbance—Docetaxel—melanoma	0.000844	0.00209	CcSEcCtD
Octreotide—Hepatitis—Temozolomide—melanoma	0.000832	0.00206	CcSEcCtD
Octreotide—Asthenia—Vemurafenib—melanoma	0.00083	0.00206	CcSEcCtD
Octreotide—Visual impairment—Carmustine—melanoma	0.000829	0.00206	CcSEcCtD
Octreotide—Hypoaesthesia—Temozolomide—melanoma	0.000828	0.00205	CcSEcCtD
Octreotide—Pharyngitis—Temozolomide—melanoma	0.000825	0.00205	CcSEcCtD
Octreotide—Oedema peripheral—Temozolomide—melanoma	0.000819	0.00203	CcSEcCtD
Octreotide—Pruritus—Vemurafenib—melanoma	0.000818	0.00203	CcSEcCtD
Octreotide—Alopecia—Dactinomycin—melanoma	0.000813	0.00201	CcSEcCtD
Octreotide—Visual impairment—Temozolomide—melanoma	0.000802	0.00199	CcSEcCtD
Octreotide—Erythema—Dactinomycin—melanoma	0.0008	0.00198	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.0008	0.00198	CcSEcCtD
Octreotide—Pain in extremity—Docetaxel—melanoma	0.0008	0.00198	CcSEcCtD
Octreotide—Flushing—Carmustine—melanoma	0.000799	0.00198	CcSEcCtD
Octreotide—Ill-defined disorder—Bleomycin—melanoma	0.000796	0.00197	CcSEcCtD
Octreotide—Anaemia—Bleomycin—melanoma	0.000793	0.00197	CcSEcCtD
Octreotide—Diarrhoea—Vemurafenib—melanoma	0.000791	0.00196	CcSEcCtD
Octreotide—Tinnitus—Temozolomide—melanoma	0.000775	0.00192	CcSEcCtD
Octreotide—Malaise—Bleomycin—melanoma	0.000774	0.00192	CcSEcCtD
Octreotide—Flushing—Temozolomide—melanoma	0.000772	0.00191	CcSEcCtD
Octreotide—Cardiac disorder—Temozolomide—melanoma	0.000772	0.00191	CcSEcCtD
Octreotide—Arrhythmia—Carmustine—melanoma	0.000769	0.00191	CcSEcCtD
Octreotide—Dizziness—Vemurafenib—melanoma	0.000765	0.0019	CcSEcCtD
Octreotide—Alopecia—Carmustine—melanoma	0.000761	0.00189	CcSEcCtD
Octreotide—Mental disorder—Carmustine—melanoma	0.000754	0.00187	CcSEcCtD
Octreotide—Immune system disorder—Temozolomide—melanoma	0.000751	0.00186	CcSEcCtD
Octreotide—Erythema—Carmustine—melanoma	0.000749	0.00186	CcSEcCtD
Octreotide—Malnutrition—Carmustine—melanoma	0.000749	0.00186	CcSEcCtD
Octreotide—Cough—Bleomycin—melanoma	0.000749	0.00186	CcSEcCtD
Octreotide—Dehydration—Docetaxel—melanoma	0.000744	0.00184	CcSEcCtD
Octreotide—Ill-defined disorder—Dactinomycin—melanoma	0.000743	0.00184	CcSEcCtD
Octreotide—Anaemia—Dactinomycin—melanoma	0.00074	0.00183	CcSEcCtD
Octreotide—Vomiting—Vemurafenib—melanoma	0.000735	0.00182	CcSEcCtD
Octreotide—Alopecia—Temozolomide—melanoma	0.000735	0.00182	CcSEcCtD
Octreotide—Dry skin—Docetaxel—melanoma	0.000733	0.00182	CcSEcCtD
Octreotide—Myalgia—Bleomycin—melanoma	0.000731	0.00181	CcSEcCtD
Octreotide—Chest pain—Bleomycin—melanoma	0.000731	0.00181	CcSEcCtD
Octreotide—Abdominal pain upper—Docetaxel—melanoma	0.00073	0.00181	CcSEcCtD
Octreotide—Rash—Vemurafenib—melanoma	0.000729	0.00181	CcSEcCtD
Octreotide—Mental disorder—Temozolomide—melanoma	0.000729	0.00181	CcSEcCtD
Octreotide—Dermatitis—Vemurafenib—melanoma	0.000728	0.00181	CcSEcCtD
Octreotide—Back pain—Carmustine—melanoma	0.000725	0.0018	CcSEcCtD
Octreotide—Headache—Vemurafenib—melanoma	0.000724	0.0018	CcSEcCtD
Octreotide—Erythema—Temozolomide—melanoma	0.000724	0.0018	CcSEcCtD
Octreotide—Malnutrition—Temozolomide—melanoma	0.000724	0.0018	CcSEcCtD
Octreotide—Discomfort—Bleomycin—melanoma	0.000722	0.00179	CcSEcCtD
Octreotide—Malaise—Dactinomycin—melanoma	0.000722	0.00179	CcSEcCtD
Octreotide—Cramp muscle—Docetaxel—melanoma	0.00072	0.00179	CcSEcCtD
Octreotide—Nasopharyngitis—Docetaxel—melanoma	0.000715	0.00177	CcSEcCtD
Octreotide—Vision blurred—Carmustine—melanoma	0.000706	0.00175	CcSEcCtD
Octreotide—Tremor—Carmustine—melanoma	0.000702	0.00174	CcSEcCtD
Octreotide—Anaphylactic shock—Bleomycin—melanoma	0.0007	0.00174	CcSEcCtD
Octreotide—Oedema—Bleomycin—melanoma	0.0007	0.00174	CcSEcCtD
Octreotide—Back pain—Temozolomide—melanoma	0.0007	0.00174	CcSEcCtD
Octreotide—Infection—Bleomycin—melanoma	0.000696	0.00173	CcSEcCtD
Octreotide—Anaemia—Carmustine—melanoma	0.000692	0.00172	CcSEcCtD
Octreotide—Agitation—Carmustine—melanoma	0.000688	0.00171	CcSEcCtD
Octreotide—Nausea—Vemurafenib—melanoma	0.000687	0.0017	CcSEcCtD
Octreotide—Thrombocytopenia—Bleomycin—melanoma	0.000686	0.0017	CcSEcCtD
Octreotide—Vision blurred—Temozolomide—melanoma	0.000682	0.00169	CcSEcCtD
Octreotide—Myalgia—Dactinomycin—melanoma	0.000681	0.00169	CcSEcCtD
Octreotide—Bronchospasm—Docetaxel—melanoma	0.00068	0.00169	CcSEcCtD
Octreotide—Tremor—Temozolomide—melanoma	0.000678	0.00168	CcSEcCtD
Octreotide—Discomfort—Dactinomycin—melanoma	0.000673	0.00167	CcSEcCtD
Octreotide—Ill-defined disorder—Temozolomide—melanoma	0.000672	0.00167	CcSEcCtD
Octreotide—Anaemia—Temozolomide—melanoma	0.000669	0.00166	CcSEcCtD
Octreotide—Anorexia—Bleomycin—melanoma	0.000668	0.00166	CcSEcCtD
Octreotide—Agitation—Temozolomide—melanoma	0.000665	0.00165	CcSEcCtD
Octreotide—Oedema—Dactinomycin—melanoma	0.000653	0.00162	CcSEcCtD
Octreotide—Malaise—Temozolomide—melanoma	0.000653	0.00162	CcSEcCtD
Octreotide—Vertigo—Temozolomide—melanoma	0.00065	0.00161	CcSEcCtD
Octreotide—Convulsion—Carmustine—melanoma	0.000649	0.00161	CcSEcCtD
Octreotide—Infection—Dactinomycin—melanoma	0.000649	0.00161	CcSEcCtD
Octreotide—Hypertension—Carmustine—melanoma	0.000647	0.0016	CcSEcCtD
Octreotide—Palpitations—Temozolomide—melanoma	0.00064	0.00159	CcSEcCtD
Octreotide—Thrombocytopenia—Dactinomycin—melanoma	0.00064	0.00159	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000638	0.00158	CcSEcCtD
Octreotide—Chest pain—Carmustine—melanoma	0.000638	0.00158	CcSEcCtD
Octreotide—Myalgia—Carmustine—melanoma	0.000638	0.00158	CcSEcCtD
Octreotide—Anxiety—Carmustine—melanoma	0.000636	0.00158	CcSEcCtD
Octreotide—Cough—Temozolomide—melanoma	0.000632	0.00157	CcSEcCtD
Octreotide—Paraesthesia—Bleomycin—melanoma	0.000629	0.00156	CcSEcCtD
Octreotide—Weight increased—Docetaxel—melanoma	0.000629	0.00156	CcSEcCtD
Octreotide—Convulsion—Temozolomide—melanoma	0.000627	0.00156	CcSEcCtD
Octreotide—Weight decreased—Docetaxel—melanoma	0.000625	0.00155	CcSEcCtD
Octreotide—Hypertension—Temozolomide—melanoma	0.000625	0.00155	CcSEcCtD
Octreotide—Dyspnoea—Bleomycin—melanoma	0.000625	0.00155	CcSEcCtD
Octreotide—Anorexia—Dactinomycin—melanoma	0.000623	0.00154	CcSEcCtD
Octreotide—Pneumonia—Docetaxel—melanoma	0.00062	0.00154	CcSEcCtD
Octreotide—Arthralgia—Temozolomide—melanoma	0.000616	0.00153	CcSEcCtD
Octreotide—Myalgia—Temozolomide—melanoma	0.000616	0.00153	CcSEcCtD
Octreotide—Anxiety—Temozolomide—melanoma	0.000614	0.00152	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000612	0.00152	CcSEcCtD
Octreotide—Oedema—Carmustine—melanoma	0.000611	0.00152	CcSEcCtD
Octreotide—Discomfort—Temozolomide—melanoma	0.000609	0.00151	CcSEcCtD
Octreotide—Decreased appetite—Bleomycin—melanoma	0.000609	0.00151	CcSEcCtD
Octreotide—Infection—Carmustine—melanoma	0.000607	0.00151	CcSEcCtD
Octreotide—Neuropathy peripheral—Docetaxel—melanoma	0.000604	0.0015	CcSEcCtD
Octreotide—Dry mouth—Temozolomide—melanoma	0.000603	0.00149	CcSEcCtD
Octreotide—Jaundice—Docetaxel—melanoma	0.000601	0.00149	CcSEcCtD
Octreotide—Pain—Bleomycin—melanoma	0.000599	0.00149	CcSEcCtD
Octreotide—Conjunctivitis—Docetaxel—melanoma	0.000599	0.00148	CcSEcCtD
Octreotide—Thrombocytopenia—Carmustine—melanoma	0.000599	0.00148	CcSEcCtD
Octreotide—Tachycardia—Carmustine—melanoma	0.000597	0.00148	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000595	0.00148	CcSEcCtD
Octreotide—MPO—lymph node—melanoma	0.000593	0.0239	CbGeAlD
Octreotide—Anaphylactic shock—Temozolomide—melanoma	0.000591	0.00147	CcSEcCtD
Octreotide—Oedema—Temozolomide—melanoma	0.000591	0.00147	CcSEcCtD
Octreotide—Infection—Temozolomide—melanoma	0.000587	0.00146	CcSEcCtD
Octreotide—Anorexia—Carmustine—melanoma	0.000583	0.00145	CcSEcCtD
Octreotide—Hepatobiliary disease—Docetaxel—melanoma	0.000583	0.00144	CcSEcCtD
Octreotide—Epistaxis—Docetaxel—melanoma	0.000581	0.00144	CcSEcCtD
Octreotide—Nervous system disorder—Temozolomide—melanoma	0.000579	0.00144	CcSEcCtD
Octreotide—Thrombocytopenia—Temozolomide—melanoma	0.000579	0.00143	CcSEcCtD
Octreotide—Feeling abnormal—Bleomycin—melanoma	0.000577	0.00143	CcSEcCtD
Octreotide—Skin disorder—Temozolomide—melanoma	0.000574	0.00142	CcSEcCtD
Octreotide—Hyperhidrosis—Temozolomide—melanoma	0.000571	0.00142	CcSEcCtD
Octreotide—Decreased appetite—Dactinomycin—melanoma	0.000568	0.00141	CcSEcCtD
Octreotide—Fatigue—Dactinomycin—melanoma	0.000563	0.0014	CcSEcCtD
Octreotide—Anorexia—Temozolomide—melanoma	0.000563	0.0014	CcSEcCtD
Octreotide—Pain—Dactinomycin—melanoma	0.000559	0.00139	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Carmustine—melanoma	0.000557	0.00138	CcSEcCtD
Octreotide—Urticaria—Bleomycin—melanoma	0.000556	0.00138	CcSEcCtD
Octreotide—Rhinitis—Docetaxel—melanoma	0.000554	0.00137	CcSEcCtD
Octreotide—Body temperature increased—Bleomycin—melanoma	0.000554	0.00137	CcSEcCtD
Octreotide—Hepatitis—Docetaxel—melanoma	0.000553	0.00137	CcSEcCtD
Octreotide—Insomnia—Carmustine—melanoma	0.000553	0.00137	CcSEcCtD
Octreotide—Hypoaesthesia—Docetaxel—melanoma	0.00055	0.00136	CcSEcCtD
Octreotide—Paraesthesia—Carmustine—melanoma	0.000549	0.00136	CcSEcCtD
Octreotide—Pharyngitis—Docetaxel—melanoma	0.000549	0.00136	CcSEcCtD
Octreotide—Dyspnoea—Carmustine—melanoma	0.000545	0.00135	CcSEcCtD
Octreotide—Oedema peripheral—Docetaxel—melanoma	0.000545	0.00135	CcSEcCtD
Octreotide—Somnolence—Carmustine—melanoma	0.000544	0.00135	CcSEcCtD
Octreotide—Feeling abnormal—Dactinomycin—melanoma	0.000538	0.00133	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000538	0.00133	CcSEcCtD
Octreotide—Insomnia—Temozolomide—melanoma	0.000534	0.00133	CcSEcCtD
Octreotide—Gastrointestinal pain—Dactinomycin—melanoma	0.000534	0.00132	CcSEcCtD
Octreotide—Visual impairment—Docetaxel—melanoma	0.000533	0.00132	CcSEcCtD
Octreotide—Decreased appetite—Carmustine—melanoma	0.000532	0.00132	CcSEcCtD
Octreotide—Paraesthesia—Temozolomide—melanoma	0.000531	0.00132	CcSEcCtD
Octreotide—Gastrointestinal disorder—Carmustine—melanoma	0.000528	0.00131	CcSEcCtD
Octreotide—Dyspnoea—Temozolomide—melanoma	0.000527	0.00131	CcSEcCtD
Octreotide—Somnolence—Temozolomide—melanoma	0.000525	0.0013	CcSEcCtD
Octreotide—Pain—Carmustine—melanoma	0.000523	0.0013	CcSEcCtD
Octreotide—Constipation—Carmustine—melanoma	0.000523	0.0013	CcSEcCtD
Octreotide—Dyspepsia—Temozolomide—melanoma	0.00052	0.00129	CcSEcCtD
Octreotide—Body temperature increased—Dactinomycin—melanoma	0.000516	0.00128	CcSEcCtD
Octreotide—Abdominal pain—Dactinomycin—melanoma	0.000516	0.00128	CcSEcCtD
Octreotide—Hypersensitivity—Bleomycin—melanoma	0.000516	0.00128	CcSEcCtD
Octreotide—Decreased appetite—Temozolomide—melanoma	0.000514	0.00127	CcSEcCtD
Octreotide—Flushing—Docetaxel—melanoma	0.000513	0.00127	CcSEcCtD
Octreotide—Cardiac disorder—Docetaxel—melanoma	0.000513	0.00127	CcSEcCtD
Octreotide—Gastrointestinal disorder—Temozolomide—melanoma	0.00051	0.00126	CcSEcCtD
Octreotide—Fatigue—Temozolomide—melanoma	0.000509	0.00126	CcSEcCtD
Octreotide—Pain—Temozolomide—melanoma	0.000505	0.00125	CcSEcCtD
Octreotide—Constipation—Temozolomide—melanoma	0.000505	0.00125	CcSEcCtD
Octreotide—Feeling abnormal—Carmustine—melanoma	0.000504	0.00125	CcSEcCtD
Octreotide—Asthenia—Bleomycin—melanoma	0.000503	0.00125	CcSEcCtD
Octreotide—Gastrointestinal pain—Carmustine—melanoma	0.0005	0.00124	CcSEcCtD
Octreotide—Immune system disorder—Docetaxel—melanoma	0.0005	0.00124	CcSEcCtD
Octreotide—Pruritus—Bleomycin—melanoma	0.000496	0.00123	CcSEcCtD
Octreotide—Arrhythmia—Docetaxel—melanoma	0.000494	0.00123	CcSEcCtD
Octreotide—Alopecia—Docetaxel—melanoma	0.000489	0.00121	CcSEcCtD
Octreotide—Feeling abnormal—Temozolomide—melanoma	0.000487	0.00121	CcSEcCtD
Octreotide—Mental disorder—Docetaxel—melanoma	0.000485	0.0012	CcSEcCtD
Octreotide—Abdominal pain—Carmustine—melanoma	0.000483	0.0012	CcSEcCtD
Octreotide—Body temperature increased—Carmustine—melanoma	0.000483	0.0012	CcSEcCtD
Octreotide—Gastrointestinal pain—Temozolomide—melanoma	0.000483	0.0012	CcSEcCtD
Octreotide—Erythema—Docetaxel—melanoma	0.000481	0.00119	CcSEcCtD
Octreotide—Malnutrition—Docetaxel—melanoma	0.000481	0.00119	CcSEcCtD
Octreotide—Hypersensitivity—Dactinomycin—melanoma	0.000481	0.00119	CcSEcCtD
Octreotide—Urticaria—Temozolomide—melanoma	0.000469	0.00116	CcSEcCtD
Octreotide—Asthenia—Dactinomycin—melanoma	0.000469	0.00116	CcSEcCtD
Octreotide—Abdominal pain—Temozolomide—melanoma	0.000467	0.00116	CcSEcCtD
Octreotide—Body temperature increased—Temozolomide—melanoma	0.000467	0.00116	CcSEcCtD
Octreotide—Back pain—Docetaxel—melanoma	0.000466	0.00115	CcSEcCtD
Octreotide—Muscle spasms—Docetaxel—melanoma	0.000463	0.00115	CcSEcCtD
Octreotide—Hypersensitivity—Carmustine—melanoma	0.00045	0.00112	CcSEcCtD
Octreotide—Diarrhoea—Dactinomycin—melanoma	0.000447	0.00111	CcSEcCtD
Octreotide—Vomiting—Bleomycin—melanoma	0.000445	0.0011	CcSEcCtD
Octreotide—Anaemia—Docetaxel—melanoma	0.000445	0.0011	CcSEcCtD
Octreotide—Rash—Bleomycin—melanoma	0.000442	0.0011	CcSEcCtD
Octreotide—Dermatitis—Bleomycin—melanoma	0.000441	0.00109	CcSEcCtD
Octreotide—Asthenia—Carmustine—melanoma	0.000439	0.00109	CcSEcCtD
Octreotide—Hypersensitivity—Temozolomide—melanoma	0.000435	0.00108	CcSEcCtD
Octreotide—Syncope—Docetaxel—melanoma	0.000432	0.00107	CcSEcCtD
Octreotide—Palpitations—Docetaxel—melanoma	0.000425	0.00105	CcSEcCtD
Octreotide—Asthenia—Temozolomide—melanoma	0.000424	0.00105	CcSEcCtD
Octreotide—Loss of consciousness—Docetaxel—melanoma	0.000423	0.00105	CcSEcCtD
Octreotide—Cough—Docetaxel—melanoma	0.00042	0.00104	CcSEcCtD
Octreotide—Diarrhoea—Carmustine—melanoma	0.000418	0.00104	CcSEcCtD
Octreotide—Pruritus—Temozolomide—melanoma	0.000418	0.00104	CcSEcCtD
Octreotide—Convulsion—Docetaxel—melanoma	0.000417	0.00103	CcSEcCtD
Octreotide—Nausea—Bleomycin—melanoma	0.000416	0.00103	CcSEcCtD
Octreotide—Hypertension—Docetaxel—melanoma	0.000416	0.00103	CcSEcCtD
Octreotide—Vomiting—Dactinomycin—melanoma	0.000415	0.00103	CcSEcCtD
Octreotide—Rash—Dactinomycin—melanoma	0.000412	0.00102	CcSEcCtD
Octreotide—Chest pain—Docetaxel—melanoma	0.00041	0.00102	CcSEcCtD
Octreotide—Arthralgia—Docetaxel—melanoma	0.00041	0.00102	CcSEcCtD
Octreotide—Myalgia—Docetaxel—melanoma	0.00041	0.00102	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000407	0.00101	CcSEcCtD
Octreotide—Dizziness—Carmustine—melanoma	0.000404	0.001	CcSEcCtD
Octreotide—Diarrhoea—Temozolomide—melanoma	0.000404	0.001	CcSEcCtD
Octreotide—Dry mouth—Docetaxel—melanoma	0.000401	0.000994	CcSEcCtD
Octreotide—Oedema—Docetaxel—melanoma	0.000393	0.000974	CcSEcCtD
Octreotide—Anaphylactic shock—Docetaxel—melanoma	0.000393	0.000974	CcSEcCtD
Octreotide—Dizziness—Temozolomide—melanoma	0.000391	0.000969	CcSEcCtD
Octreotide—Infection—Docetaxel—melanoma	0.00039	0.000968	CcSEcCtD
Octreotide—Vomiting—Carmustine—melanoma	0.000389	0.000964	CcSEcCtD
Octreotide—Nausea—Dactinomycin—melanoma	0.000388	0.000962	CcSEcCtD
Octreotide—Shock—Docetaxel—melanoma	0.000387	0.000959	CcSEcCtD
Octreotide—Rash—Carmustine—melanoma	0.000386	0.000956	CcSEcCtD
Octreotide—Nervous system disorder—Docetaxel—melanoma	0.000385	0.000955	CcSEcCtD
Octreotide—Dermatitis—Carmustine—melanoma	0.000385	0.000955	CcSEcCtD
Octreotide—Thrombocytopenia—Docetaxel—melanoma	0.000385	0.000954	CcSEcCtD
Octreotide—Tachycardia—Docetaxel—melanoma	0.000384	0.000951	CcSEcCtD
Octreotide—Headache—Carmustine—melanoma	0.000383	0.00095	CcSEcCtD
Octreotide—Skin disorder—Docetaxel—melanoma	0.000382	0.000946	CcSEcCtD
Octreotide—Vomiting—Temozolomide—melanoma	0.000376	0.000931	CcSEcCtD
Octreotide—Anorexia—Docetaxel—melanoma	0.000375	0.000929	CcSEcCtD
Octreotide—Rash—Temozolomide—melanoma	0.000373	0.000924	CcSEcCtD
Octreotide—Dermatitis—Temozolomide—melanoma	0.000372	0.000923	CcSEcCtD
Octreotide—Headache—Temozolomide—melanoma	0.00037	0.000918	CcSEcCtD
Octreotide—Nausea—Carmustine—melanoma	0.000363	0.0009	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000358	0.000888	CcSEcCtD
Octreotide—Insomnia—Docetaxel—melanoma	0.000355	0.000881	CcSEcCtD
Octreotide—Paraesthesia—Docetaxel—melanoma	0.000353	0.000875	CcSEcCtD
Octreotide—Nausea—Temozolomide—melanoma	0.000351	0.00087	CcSEcCtD
Octreotide—Dyspnoea—Docetaxel—melanoma	0.00035	0.000869	CcSEcCtD
Octreotide—Somnolence—Docetaxel—melanoma	0.000349	0.000866	CcSEcCtD
Octreotide—Dyspepsia—Docetaxel—melanoma	0.000346	0.000858	CcSEcCtD
Octreotide—Decreased appetite—Docetaxel—melanoma	0.000342	0.000847	CcSEcCtD
Octreotide—Gastrointestinal disorder—Docetaxel—melanoma	0.000339	0.000841	CcSEcCtD
Octreotide—Fatigue—Docetaxel—melanoma	0.000339	0.00084	CcSEcCtD
Octreotide—Constipation—Docetaxel—melanoma	0.000336	0.000833	CcSEcCtD
Octreotide—Pain—Docetaxel—melanoma	0.000336	0.000833	CcSEcCtD
Octreotide—Feeling abnormal—Docetaxel—melanoma	0.000324	0.000803	CcSEcCtD
Octreotide—Gastrointestinal pain—Docetaxel—melanoma	0.000321	0.000797	CcSEcCtD
Octreotide—Abdominal pain—Docetaxel—melanoma	0.000311	0.00077	CcSEcCtD
Octreotide—Body temperature increased—Docetaxel—melanoma	0.000311	0.00077	CcSEcCtD
Octreotide—Hypersensitivity—Docetaxel—melanoma	0.00029	0.000718	CcSEcCtD
Octreotide—Asthenia—Docetaxel—melanoma	0.000282	0.000699	CcSEcCtD
Octreotide—Pruritus—Docetaxel—melanoma	0.000278	0.000689	CcSEcCtD
Octreotide—Diarrhoea—Docetaxel—melanoma	0.000269	0.000667	CcSEcCtD
Octreotide—Dizziness—Docetaxel—melanoma	0.00026	0.000644	CcSEcCtD
Octreotide—Vomiting—Docetaxel—melanoma	0.00025	0.000619	CcSEcCtD
Octreotide—Rash—Docetaxel—melanoma	0.000248	0.000614	CcSEcCtD
Octreotide—Dermatitis—Docetaxel—melanoma	0.000248	0.000614	CcSEcCtD
Octreotide—Headache—Docetaxel—melanoma	0.000246	0.00061	CcSEcCtD
Octreotide—Nausea—Docetaxel—melanoma	0.000233	0.000579	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—melanoma	8.19e-05	0.000143	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF1—melanoma	8.08e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CSF2—melanoma	8.08e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FN1—melanoma	8.08e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—melanoma	8.07e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KDR—melanoma	8.05e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MDM2—melanoma	8.03e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—melanoma	7.96e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB2—melanoma	7.92e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOTCH1—melanoma	7.91e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—E2F1—melanoma	7.91e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—melanoma	7.87e-05	0.000138	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—melanoma	7.83e-05	0.000137	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PDGFRA—melanoma	7.82e-05	0.000137	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—melanoma	7.82e-05	0.000137	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—melanoma	7.8e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RAC1—melanoma	7.78e-05	0.000136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PRKCA—melanoma	7.74e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ITGB3—melanoma	7.74e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FN1—melanoma	7.74e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD80—melanoma	7.74e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—melanoma	7.73e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KIT—melanoma	7.73e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—melanoma	7.73e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NRAS—melanoma	7.73e-05	0.000135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGF—melanoma	7.64e-05	0.000134	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—melanoma	7.6e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH1—melanoma	7.58e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAP2K2—melanoma	7.57e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—melanoma	7.56e-05	0.000132	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—melanoma	7.51e-05	0.000131	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—melanoma	7.46e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—melanoma	7.46e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CD80—melanoma	7.43e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—melanoma	7.41e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—melanoma	7.41e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—melanoma	7.41e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NRAS—melanoma	7.41e-05	0.00013	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK3—melanoma	7.4e-05	0.000129	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—melanoma	7.34e-05	0.000128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGF—melanoma	7.33e-05	0.000128	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BRAF—melanoma	7.27e-05	0.000127	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—melanoma	7.26e-05	0.000127	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—melanoma	7.23e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—melanoma	7.2e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—melanoma	7.19e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RAC1—melanoma	7.18e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—melanoma	7.18e-05	0.000126	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—melanoma	7.14e-05	0.000125	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KDR—melanoma	7.14e-05	0.000125	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK3—melanoma	7.1e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—melanoma	7.08e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK1—melanoma	7.04e-05	0.000123	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—melanoma	7.04e-05	0.000123	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—melanoma	7e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—melanoma	6.97e-05	0.000122	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—melanoma	6.93e-05	0.000121	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIF1A—melanoma	6.89e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FN1—melanoma	6.87e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAP2K1—melanoma	6.84e-05	0.00012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—melanoma	6.8e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—melanoma	6.79e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—melanoma	6.79e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1A—melanoma	6.77e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—melanoma	6.75e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK1—melanoma	6.75e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—melanoma	6.75e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—melanoma	6.73e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH1—melanoma	6.72e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NFKB1—melanoma	6.72e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—melanoma	6.65e-05	0.000116	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—melanoma	6.59e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CD80—melanoma	6.59e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KDR—melanoma	6.59e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—melanoma	6.57e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—melanoma	6.57e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—melanoma	6.57e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—melanoma	6.57e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAP2K1—melanoma	6.56e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—melanoma	6.52e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGF2—melanoma	6.51e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGF—melanoma	6.5e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—melanoma	6.45e-05	0.000113	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—melanoma	6.38e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FN1—melanoma	6.34e-05	0.000111	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK3—melanoma	6.3e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGF2—melanoma	6.24e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH1—melanoma	6.2e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BRAF—melanoma	6.18e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—melanoma	6.11e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—melanoma	6.1e-05	0.000107	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MDM2—melanoma	6.09e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD80—melanoma	6.08e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—melanoma	6.07e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—melanoma	6.07e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—melanoma	6.07e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—melanoma	6.07e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—melanoma	6.04e-05	0.000106	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NRAS—melanoma	6.03e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—melanoma	6.02e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—melanoma	6e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGF—melanoma	6e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK1—melanoma	5.99e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—melanoma	5.99e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—melanoma	5.92e-05	0.000104	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—melanoma	5.86e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MDM2—melanoma	5.84e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAP2K1—melanoma	5.82e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK3—melanoma	5.81e-05	0.000102	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—melanoma	5.78e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK3—melanoma	5.77e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB2—melanoma	5.75e-05	0.000101	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—melanoma	5.72e-05	0.0001	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—melanoma	5.7e-05	9.97e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—melanoma	5.69e-05	9.95e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—melanoma	5.68e-05	9.93e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—melanoma	5.66e-05	9.89e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—melanoma	5.66e-05	9.89e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—melanoma	5.61e-05	9.82e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—melanoma	5.56e-05	9.72e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—melanoma	5.55e-05	9.71e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF2—melanoma	5.53e-05	9.68e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK1—melanoma	5.53e-05	9.67e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—melanoma	5.53e-05	9.66e-05	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—melanoma	5.5e-05	9.62e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK1—melanoma	5.49e-05	9.6e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—melanoma	5.49e-05	9.6e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—melanoma	5.46e-05	9.54e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—melanoma	5.45e-05	9.53e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—melanoma	5.44e-05	9.51e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—melanoma	5.42e-05	9.48e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—melanoma	5.41e-05	9.47e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAP2K1—melanoma	5.37e-05	9.39e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—melanoma	5.33e-05	9.33e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—melanoma	5.33e-05	9.32e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—melanoma	5.3e-05	9.27e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—melanoma	5.28e-05	9.24e-05	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—melanoma	5.27e-05	9.22e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—melanoma	5.25e-05	9.18e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—melanoma	5.22e-05	9.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—melanoma	5.22e-05	9.13e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—melanoma	5.22e-05	9.12e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—melanoma	5.2e-05	9.09e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—melanoma	5.19e-05	9.07e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—melanoma	5.19e-05	9.07e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MDM2—melanoma	5.18e-05	9.05e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—melanoma	5.15e-05	9e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1A—melanoma	5.13e-05	8.97e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—melanoma	5.12e-05	8.95e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGF2—melanoma	5.11e-05	8.93e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—melanoma	5.1e-05	8.93e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NFKB1—melanoma	5.09e-05	8.91e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—melanoma	5.08e-05	8.89e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—melanoma	5.04e-05	8.81e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—melanoma	5.04e-05	8.8e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—melanoma	4.99e-05	8.73e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—melanoma	4.94e-05	8.63e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1A—melanoma	4.92e-05	8.6e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—melanoma	4.91e-05	8.58e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NFKB1—melanoma	4.88e-05	8.54e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—melanoma	4.84e-05	8.46e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—melanoma	4.81e-05	8.41e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—melanoma	4.8e-05	8.39e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—melanoma	4.79e-05	8.37e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MDM2—melanoma	4.78e-05	8.35e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—melanoma	4.76e-05	8.33e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—melanoma	4.73e-05	8.27e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—melanoma	4.71e-05	8.24e-05	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—melanoma	4.68e-05	8.18e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—melanoma	4.65e-05	8.13e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—melanoma	4.63e-05	8.1e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—melanoma	4.63e-05	8.09e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—melanoma	4.62e-05	8.08e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—melanoma	4.61e-05	8.06e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—melanoma	4.6e-05	8.05e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—melanoma	4.58e-05	8.01e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—melanoma	4.57e-05	7.99e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—melanoma	4.51e-05	7.89e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—melanoma	4.47e-05	7.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—melanoma	4.47e-05	7.81e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—melanoma	4.44e-05	7.76e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—melanoma	4.43e-05	7.75e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—melanoma	4.41e-05	7.71e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—melanoma	4.39e-05	7.67e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—melanoma	4.38e-05	7.66e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—melanoma	4.38e-05	7.66e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK3—melanoma	4.37e-05	7.65e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1A—melanoma	4.36e-05	7.63e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—melanoma	4.36e-05	7.63e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—melanoma	4.35e-05	7.61e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NFKB1—melanoma	4.33e-05	7.57e-05	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—melanoma	4.32e-05	7.55e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—melanoma	4.28e-05	7.48e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—melanoma	4.27e-05	7.46e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—melanoma	4.25e-05	7.44e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—melanoma	4.25e-05	7.43e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—melanoma	4.25e-05	7.42e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—melanoma	4.22e-05	7.38e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK3—melanoma	4.19e-05	7.33e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—melanoma	4.16e-05	7.28e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK1—melanoma	4.16e-05	7.28e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—melanoma	4.16e-05	7.28e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—melanoma	4.12e-05	7.21e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—melanoma	4.08e-05	7.13e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—melanoma	4.04e-05	7.07e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1A—melanoma	4.03e-05	7.04e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—melanoma	4.02e-05	7.02e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NFKB1—melanoma	4e-05	6.99e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK1—melanoma	3.99e-05	6.98e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—melanoma	3.99e-05	6.98e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—melanoma	3.93e-05	6.87e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—melanoma	3.93e-05	6.87e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—melanoma	3.92e-05	6.85e-05	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—melanoma	3.89e-05	6.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—melanoma	3.89e-05	6.81e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—melanoma	3.88e-05	6.79e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—melanoma	3.77e-05	6.59e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK3—melanoma	3.72e-05	6.5e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—melanoma	3.63e-05	6.34e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—melanoma	3.62e-05	6.32e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—melanoma	3.61e-05	6.31e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—melanoma	3.59e-05	6.28e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—melanoma	3.58e-05	6.27e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK1—melanoma	3.54e-05	6.19e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—melanoma	3.54e-05	6.19e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—melanoma	3.49e-05	6.11e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—melanoma	3.46e-05	6.05e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK3—melanoma	3.43e-05	6e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—melanoma	3.35e-05	5.86e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—melanoma	3.34e-05	5.84e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—melanoma	3.34e-05	5.84e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—melanoma	3.34e-05	5.84e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK1—melanoma	3.27e-05	5.71e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—melanoma	3.26e-05	5.71e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—melanoma	3.2e-05	5.6e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—melanoma	3.2e-05	5.59e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—melanoma	3.08e-05	5.39e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—melanoma	3.07e-05	5.37e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—melanoma	3.07e-05	5.36e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—melanoma	2.97e-05	5.19e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—melanoma	2.95e-05	5.16e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—melanoma	2.84e-05	4.97e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—melanoma	2.83e-05	4.96e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—melanoma	2.83e-05	4.95e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—melanoma	2.74e-05	4.79e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—melanoma	2.72e-05	4.75e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—melanoma	2.62e-05	4.58e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—melanoma	2.51e-05	4.39e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—melanoma	2.51e-05	4.39e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—melanoma	2.31e-05	4.05e-05	CbGpPWpGaD
